,v’ v

~J ﬂuff Wm'w Mme”
Procedure Dale: CW-W, W ”7 l W 7,09

= 80193
Procedure Physmian; 5 «+4 : W/ No 5 c 50. ‘2 /3
AmendMgmemaanamxwesTo _ _

 

[AJI/u
,4,
mm H.310“: "Um#:“fozafzizathw“We“cm
Daggrc’gfgmmﬂ . Ill ImuumuInmummmmmmmmmmlmuu

l
Illllllllllllllllllllllllllllllllllllllllil|||||||||||
POST-OP DIAGNOSIS: SAME
OPIRATIVI PROCEDURI: RT SEC MASTECTOMY, RT CX NODE DISSECTION

(ll
lllllllHlllllllllllllll(HIllllllllllHllllllllllHllHllll

MmERRIAL SUBMITTED: A) RIGNEDBREAST BIOPSY/MASS/SEGMENTAL MBSTECTOMY, PROCUREMENT BY SURGICAL PROCEDURE
P) RIGHT AXILLARY CONT .

ll
DRE-OP DIAGNOSIS: RT BREAST CANCER H

INTRAOPIRATIVE CONSULTATION:

FROZEN SECTION: Right breast: 2 masses, 1.0 by 1.5 by 1.2 cm 0.4 cm from medial margin. Other 1.5 by 1.0 by
1.5 cm 0.5 cm from superior margin.

Frozen section diagnoeis: (tumor near medial margin): Intiltrating carcinoma with features or ductal and
lobuiar carcinoma.

FINAL DIAGNOSIS:

PREVIOUS REPORT: _-- _.

 

MAPS) RIGHT Igamsgasecﬂggm msgggggﬂwamawA—w—(um—M--v- ~~~~
~ MULTIFQCAH IN me DUCT CARCINO w ULAR AND CLEAR 1.5 BY 1.5 BY 1.0 CM AND 1.5

    

BY 1.2 BY 1.0 CM‘ INTERMEDIATE NUCLEAR GRADEI POOR A CTURAL GRADEI WITH ASSOCIATED MICROCALCIFICATIONS
— FOCAL DUCTAL CARCINOMA IN SITU, NON-COMEDO TYPE COMPRISING <5! OE TUMOR

- SURGICAL MARGINS NEGATIVE FOR TUMOR BUT TUMOR CLOSELY APPROACHES MEDIAL MARGIN (WITHIN 0.2 CM)

B) RIGHT AXILLARY CONTENTS:

- ONE (1) OF FIFTEEN (15) NODBS POSITIVE FOR TUMOR AND SHOWING EXTRA CAPSULAR EXTENSION

S U P P L E M E N T A L R B P O R T

ER/PR ~

My Signature below is attestation that I have reviewed all slides and agree with the findings as noted
below.

IMMUNOPEROXIDASE IDENTIFICATION OE‘EETROGEN AND PROGESTERONE RECEPTOR§>IS CARRIED OUT ON SLIDE al. DISTINCT
INTRANUCLEAR STAINING IS IDENTIFIED FOR BOTH ESTROGEN RECEPTOR (90%) AND PROGESTERONE RECEPTOR (90%).
THEREFORE, BOTH ARE INTERPRETED AS POSITIVE.

Pathologist

.PPLEHMENTALREPORT
HER-Z/NEU
My signature below is attestation that I have reviewed all slide: and agree with the findings as noted
below.
c—erbBZ (HER—Z/NEU) IMMUNOSTAINING IS CARRIED OUT ON BLOCK Al (BREAST CANCER) USING A 1:300 DILUTION 0F
DAKO'S POLYCLONAL ANTIBODY A485 (DIRECTED AGAINST THE INTRACELLULAR DOMAIN OF c—erbBZ) WITHOUT ANTIGEN
RETRIEVAL. NO DISTINCT COMPLETE MEMBRANE STAINING I5 IDENTIFIED. THEREFORE. c—erbBZ (HER-Z/NEU) IS
INTERPRETED AS NEGATIVE (SCORE O).

  
  
 
  
    

cmevll

. . I “‘1
Duncan D|§crepln
Primary Tumor Site Dlscrepanw
HIPAA Discrepancy.
'Pvior Malignann Hun-"v

Dull/sgnchronous Fri-nary Na -

   

